Functional Characterization of TcaA: Minimal Requirement for Teicoplanin Susceptibility and Role in Caenorhabditis elegans Virulence

Antimicrobial Agents and Chemotherapy
2007.0

Abstract

The inactivation of TcaA contributes to intrinsic teicoplanin resistance in experimental and clinical isolates of glycopeptide-intermediate resistant Staphylococcus aureus. PhoA fusions confirmed that TcaA is a transmembrane protein with a short intracellular N-terminal domain containing a C-4 zinc finger binding motif, a single membrane-spanning domain, and a large extracellular C-terminal domain. The region conferring teicoplanin susceptibility was narrowed down to the transmembrane part and the first third of the extracellular domain of TcaA, suggesting that neither the C-4 zinc finger binding motif nor the C terminus contributed to teicoplanin susceptibility. TcaA belongs to the cell wall stress stimulon, which comprises a set of genes universally upregulated by cell wall damage. Induction of tcaA was shown to be fully dependent on the two-component regulatory system VraSR. A 66-bp region upstream of the transcriptional start site, which contained an inverted repeat partially covering the promoter box, was shown to be essential for VraSR-mediated induction by cell wall stress. Interestingly, the induction or overexpression of tcaA did not contribute further to teicoplanin susceptibility, suggesting that small amounts of TcaA, such as those present under normal uninduced conditions, were sufficient for TcaA-mediated teicoplanin susceptibility. The strong attenuation of tcaA deletion mutants in a Caenorhabditis elegans survival assay suggested that TcaA may, in addition to affecting glycopeptide susceptibility, also play a role in virulence.

Knowledge Graph

Similar Paper

Functional Characterization of TcaA: Minimal Requirement for Teicoplanin Susceptibility and Role in Caenorhabditis elegans Virulence
Antimicrobial Agents and Chemotherapy 2007.0
Interaction of the GraRS Two-Component System with the VraFG ABC Transporter To Support Vancomycin-Intermediate Resistance in Staphylococcus aureus
Antimicrobial Agents and Chemotherapy 2007.0
Reduced Expression of the vca0421 Gene of Vibrio cholerae O1 Results in Innate Resistance to Ciprofloxacin
Antimicrobial Agents and Chemotherapy 2010.0
Serial Daptomycin Selection Generates Daptomycin-NonsusceptibleStaphylococcus aureusStrains with a Heterogeneous Vancomycin-Intermediate Phenotype
Antimicrobial Agents and Chemotherapy 2008.0
Staphylococcus aureus Cell Wall Stress Stimulon Gene -lacZ Fusion Strains: Potential for Use in Screening for Cell Wall-Active Antimicrobials
Antimicrobial Agents and Chemotherapy 2008.0
TelA Contributes to the Innate Resistance of Listeria monocytogenes to Nisin and Other Cell Wall-Acting Antibiotics
Antimicrobial Agents and Chemotherapy 2010.0
VanA-Type Vancomycin-ResistantStaphylococcus aureus
Antimicrobial Agents and Chemotherapy 2009.0
Characterization of Two Newly Identified Genes, vgaD and vatG , Conferring Resistance to Streptogramin A in Enterococcus faecium
Antimicrobial Agents and Chemotherapy 2010.0
Genetic Analysis of Factors Affecting Susceptibility ofBacillus subtilisto Daptomycin
Antimicrobial Agents and Chemotherapy 2009.0
Identification and Phenotypic Characterization of a β-Lactam-Dependent, Methicillin-Resistant Staphylococcus aureus Strain
Antimicrobial Agents and Chemotherapy 2007.0